导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.63% | 4358/4448 |
| 近一周 | -5.81% | 4663/4957 |
| 近一月 | -14.98% | 4917/4942 |
| 近一季 | -7.60% | 3898/4866 |
| 近半年 | 1.34% | 4142/4627 |
| 近一年 | -2.65% | 4268/4422 |
| 近两年 | 39.43% | 1351/3936 |
| 近三年 | 59.31% | 228/3301 |
| 成立以来 | 96.16% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
2.43% 2749/4617 |
-4.50% 4326/4794 |
14.14% 3617/4965 |
- - |
| 2024 | 48.65% 8/4611 |
14.55% 33/4340 |
-0.54% 1543/4440 |
18.77% 379/4543 |
9.85% 286/4611 |
| 2023 | 13.34% 47/4209 |
15.02% 118/3759 |
35.08% 2/3909 |
-14.87% 3364/4055 |
-14.31% 4007/4209 |
| 2022 | -27.83% 2148/3571 |
-16.21% 1088/2804 |
4.95% 2016/3205 |
-20.16% 3031/3430 |
2.80% 917/3570 |
| 2021 | -8.90% 1361/2712 |
0.61% 309/1745 |
12.09% 823/2232 |
-18.20% 2181/2560 |
-1.25% 1749/2708 |
| 2020 | 60.38% 428/1591 |
1.16% 328/1036 |
22.69% 591/1256 |
10.87% 599/1472 |
16.55% 518/1690 |
| 2019 | - - |
- - |
- - |
1.78% 712/939 |
7.17% 627/1014 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 国融融盛龙头严选混合C VS. () |